A basic study on Hypericin-PDT in vitro

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 3, 2012, Pages 196-203

  Nakajima, Nobue ^a,b   Kawashima, Norimichi ^a  

^a TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

ATP; Hypericin; In vitro; LED lamp; Na Li lamp; Photodynamic therapy (PDT); Photosensitiser

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYPERICIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CELL LEVEL; CELL VIABILITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; IRRADIATION; LIGHT EMITTING DIODE; LYMPHOMA CELL LINE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION DOSE;

APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIATION DOSAGE; U937 CELLS;

EID: 84865966155     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.01.008     Document Type: Article

References (36)

1. Sancar A. Cryptochrome: the second photoactive pigment in the eye and its role in circadian photoreception. Review of Biochemistry 2000, 69:31-67.
2. Belyaeeva O.B., Litvin F.F. Photoactive pigment-enzyme complexes of chlorophyll precursor in plant leaves. Biochemistry (Moscow) 2007, 47:189-232.
3. Hartmann G.C., Marks L.M., Yang C.C. Physical models for photoactive pigment electrophotography. Journal of Applied Physics 2009, 47:5409-5420.
4. Il'ina M.D., Borisov A.Y. The fractionation of plant photoactive pigment-protein complexes I and II. Biochimica et Biophysica Acta (BBA) Bioenergetics 1980, 590:345-352.
5. Dougherth T.J. Photodynamic therapy. Photochemistry and Photobiology 1993, 58:895-900.
6. Suzuki M., Hirose M., Kai S., Hori M., Hayashi T. Porphyrin analogs as photosensitizers in a photodynamic cancer therapy. The Annual Proceedings of Gifu Pharmaceutical University 1990.
7. Harada M. Recent advances in photodynamic therapy; an expanding role in non-small cell Lung cancer. Japanese Journal of Lung Cancer 2005, 45:687-692.
8. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nature Reviews. Cancer 2003, 3:380-387.
9. Moan J., Berg K. The photodegradation of porphyrins in cells can be used to estimate the life time of singlet oxygen. Photochemistry and Photobiology 1991, 53:549-553.
10. Cottrell W.J., Paquette A.D., Keymet K.R., Foster T.H., Oseroff A.R. Irradiance-Dependent photobleaching and pain in δ-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clinical Cancer Research 2008, 14(14):4475-4483.
11. Saller R., Strauss W.S., Wagner M., Emmert H., Schneckenburger H. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines. Photochemical and Photobiological Sciences 2007, 6(2):145-151.
12. Babilas P., Kohl E., Maisch T., et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Photobiology 2006, 154:712-718.
13. Ericson M.B., Grapengiesser S., Gudmundson F., et al. A spectroscopic study of the photobleaching of protoptoshyrin IX in solution. Lasers in Medical Science 2003, 18:56-62.
14. Wu S.M., Ren Q.G., Zhou M.O., Peng Q., Chen J.Y. Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Letters 2003, 200(2):123-131.
15. Juzeniene A., Juzenas P., Ma L.W., Iani V., Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers in Medical Science 2004, 19:139-149.
16. Papageorgiou P., Katsambas A., Ch A. Phototherapy with blue (415nm) and red (660nm) light in the treatment of acne vulgaris. British Journal of Dermatology 2000, 142:973-978.
17. Bagdonas S., Ma L.W., Iani V., Rotomskis R., Juzenas P., Moan J. Photo-transformations of 5-aminolaevulinic acid-induced protoporphyrin IX in vitro: A Spectroscopic study. Photochemistry and Photobiology 2000, 72(2):186-192.
18. Nadeau V., O'Dwyer M., Hamdan K., Tait I., Padgett M. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities. Photodermatology Photoimmunology & Photomedicin 2004, 20:170-174.
19. Agostinis P., Vantieghem A., Merievede W., de Witte P.A. Hypericin in cancer treatment: more light on the way. The International Journal of Biochemistry and Cell Biology 2002, 34:221-241.
20. Schey K.L., Patat S., Chignell C.F., Datillo M., Wang R.H., Roberts J.E. Photo-oxidation of lens alpha-crystalline by hypericin (active ingredient in St. John's Wort). Photochemistry and Photobiology 2000, 72(2):200-203.
21. Diwu Z. Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochemistry and Photobiology 1995, 61(6):529-539.
22. Duran N., Song P. Hypericin and its photodynamic action. Photochemistry and Photobiology 1986, 43:677-680.
23. Linde K., Ramirez R., Mulrow C.D., Paul A., Weldenhamer M., Melchart D. St John's wort for depression: an overview and meta-analysis of randomized clinical trials. British Medical Journal 1996, 313:253-258.
24. Lavie G., Mazur Y., Lavie D., Meruelo D. The chemical and biological properties of hypericin a compound with a broad spectrum of biological activities. Medicinal Research Reviews 1995, 15:111-119.
25. Engkish D.S., Doyle R.T., Petrich J.W., Haydon P.S. Subcellular distributions and excited-state processes of hypericin in neurons. Photochemistry and Photobiology 1999, 69:301-305.
26. Hajur C., Richard M.J., Parat M.O., Jardon P., Favier A. Photodynamic effects of hypericin of lipid peroxidation and antioxidant status in melanoma cells. Photochemistry and Photobiology 1996, 64:375-381.
27. Thomas C., Pardini R.S. Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochemistry and Photobiology 1992, 55:831-837.
28. Okpanyi S.N., Lidzba H., Scholl B.S., Miltenburger H.S. Genotoxicity of a standardized Hypericun extract. Drug Research 1990, 40:851-855.
29. Luksiene Z., De Witte P. Hypericin-based photodynamic therapy: I. Comparative antitumor activity and uptake studies in English ascite tumor. Acta Madica Lituanica 2002, 195-199.
30. D'Hallewin M.A., Kamuhabwa A.R., Roskams T., De Witte P.A.M., Baert L. Hypericin-based florescence diagnosis of bladder carcinoma. BJU International 2002, 89:760-763.
31. Head C.S., Luu Q., Sercarz J., Saxton R. Photodynamic therapy and tumor imaging of hypericin-treated squamous cell carcinoma. World Journal of Surgical Oncology 2006, 4:87-97.
32. Ho Y.F., Wu M.H., Cheng B.H., Chen Y.W., Shih M.C. Lipid-mediated preferential localization of hypericin in lipid membranes. Biochimica et Biophysica Acta 2009, BBAMEM-79906:9.
33. Zamaraeve M.V., Sabirov R.Z., Maeno E., Ando-Akatsuka Y., Bessonova S.V., Okada Y. Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death and Differentiation 2005, 12:1390-1397.
34. Eguch Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Research May 15 1997, 57:1835-1840.
35. Oberdanner C.B., Kiesslich T., Krammer B., Pletzer K. Glucose is required to maintain high ATP-levels for the energy-utilizing steps during PDT-induced apoptosis. Photochemistry and Photobiology 2002, 76(6):695-703.
36. Ruchalski K., Mao H., Singh S.K., et al. HSP72 inhibits apoptosis-inducing factor release in ATP-depleted renal epithelial cells. American Journal of Physiology. Cell Physiology 2003, 285:C1483-C1493.